Cervical cancer emerges as leading killer of women in Busoga, hospice warns

East Africa's healthcare landscape is increasingly defined by preventable diseases and social inequities that simultaneously represent significant market gaps and investment opportunities. Recent reporting from Uganda's Busoga region highlights two interconnected crises—surging cervical cancer mortality among women and persistent gender-based vulnerabilities affecting youth—that underscore the commercial potential within Uganda's underserved health and social sectors. The cervical cancer phenomenon in Busoga reflects a broader East African pattern: a disease that is almost entirely preventable through vaccination and screening, yet remains a leading cause of female mortality in regions with limited healthcare infrastructure. The root causes—poverty limiting access to screening services, late-stage diagnoses, and insufficient HPV vaccination coverage—create a compelling market dysfunction. For European health technology companies and medical device manufacturers, this represents a clear opportunity gap. The absence of affordable diagnostic tools, digital health platforms for remote screening coordination, and integrated treatment pathways leaves an addressable market largely unserved by formal commercial healthcare providers. Uganda's healthcare spending per capita remains among Africa's lowest at approximately $45 annually, yet the country's population exceeds 46 million, with 51% female. The arithmetic is straightforward: scaling even basic cervical cancer screening infrastructure across Uganda and the broader region could generate substantial returns while addressing a